All Pathways
Family MedicineManagement

Uncomplicated UTI Management (IDSA 2011)

Uncomplicated UTI Management (IDSA 2011): Suspected UTI → Complicated UTI Risk Factors? → Complicated UTI.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected UTI

    Dysuria, frequency, urgency in adult female

    1. Decision

      Complicated UTI Risk Factors?

      Requires different management

      • Male sex
      • Pregnancy
      • Diabetes
      • Immunosuppression
      • Urinary tract abnormality
      • Recent instrumentation
      • Symptoms >7 days
      • Recent antibiotic use
      1. Warning

        Complicated UTI

        Obtain culture, broader spectrum therapy

        • Urine culture before treatment
        • Fluoroquinolone or beta-lactam
        • 7-14 day course
        • Consider imaging if not improving
        • ID/urology consult if recurrent
      2. Decision

        Pyelonephritis Symptoms?

        Upper tract involvement

        • Fever >38°C
        • Flank pain or CVA tenderness
        • Nausea/vomiting
        • Systemic symptoms
        1. Action

          Acute Pyelonephritis

          Culture required, consider admission

          • Urine culture mandatory
          • Outpatient: fluoroquinolone 7 days or TMP-SMX 14 days
          • Admit if: unable to tolerate PO, pregnant, septic, obstruction suspected
          • Consider CT if not improving 48-72h
        2. Action

          Uncomplicated Cystitis

          Healthy non-pregnant female

          • Empiric treatment appropriate
          • Culture not required if classic symptoms
          • Urinalysis supportive but not required
          • High probability if dysuria + frequency without vaginal symptoms
          1. Action

            First-Line Antibiotics

            IDSA recommended agents

            • Nitrofurantoin 100mg BID x 5 days (avoid if CrCl <30)
            • TMP-SMX 160/800mg BID x 3 days (if local resistance <20%)
            • Fosfomycin 3g single dose (less effective)
            • Avoid fluoroquinolones (FDA black box warning)
            1. Action

              Alternative Antibiotics

              If allergies or resistance concerns

              • Beta-lactams: amoxicillin-clavulanate, cefpodoxime, cefdinir
              • Less effective than first-line options
              • Reserve fluoroquinolones for no other option
              • 7 days if using beta-lactam
              1. Action

                Symptomatic Relief

                Adjunctive measures

                • Phenazopyridine 200mg TID x 2 days (urine turns orange)
                • Hydration encouraged
                • Symptoms should improve 24-48h
                • Complete course even if improved
                1. Decision

                  Symptoms Resolved?

                  Assess response

                  1. Outcome

                    Resolved

                    No further action needed, return PRN

                  2. Action

                    Persistent Symptoms

                    Culture-directed therapy

                    • Obtain urine culture
                    • Consider STI testing
                    • Treat based on susceptibilities
                    • Consider ultrasound if recurrent
                    • Urology referral if anatomic concern
                    1. Action

                      Recurrent UTI (≥3/year)

                      Prevention strategies

                      • Post-coital prophylaxis: TMP-SMX or nitrofurantoin
                      • Continuous prophylaxis: low-dose nightly
                      • Self-start therapy for reliable patients
                      • Cranberry products (limited evidence)
                      • Vaginal estrogen in postmenopausal women

Guideline Source

IDSA Guidelines for Treatment of Acute Uncomplicated Cystitis and Pyelonephritis

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Applies only to uncomplicated UTI in non-pregnant women
  • Local resistance patterns should guide antibiotic choice
  • Does not address complicated UTI or pyelonephritis in detail
  • Fluoroquinolone recommendations changed due to FDA warnings
  • Asymptomatic bacteriuria treatment not addressed

Contraindicated Populations

pregnancy

Applicable Regions

USAUUKEU

AU: eTG recommends trimethoprim or nitrofurantoin first-line

UK: NICE recommends nitrofurantoin or trimethoprim

US: IDSA 2011 with updated FQ safety considerations

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Uncomplicated UTI Management (IDSA 2011)?

The Uncomplicated UTI Management (IDSA 2011) is a management clinical algorithm for Family Medicine. It provides a structured decision tree to guide clinical decision-making, based on IDSA Guidelines for Treatment of Acute Uncomplicated Cystitis and Pyelonephritis.

What guideline is the Uncomplicated UTI Management (IDSA 2011) based on?

This algorithm is based on IDSA Guidelines for Treatment of Acute Uncomplicated Cystitis and Pyelonephritis (DOI: 10.1093/cid/ciq257).

What are the limitations of the Uncomplicated UTI Management (IDSA 2011)?

Known limitations include: Applies only to uncomplicated UTI in non-pregnant women; Local resistance patterns should guide antibiotic choice; Does not address complicated UTI or pyelonephritis in detail; Fluoroquinolone recommendations changed due to FDA warnings; Asymptomatic bacteriuria treatment not addressed. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Uncomplicated UTI Management (IDSA 2011) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free